TheGBA1 gene encodes the lysosomal enzyme glucocerebrosidase, the activity of which has been found to be reduced in PD patients withoutGBA1 mutations, making it an interesting therapeutic target for a wider PD population. This evidence concerns the gene GBA1 and Parkinson disease.